The mission of this fund is to advance the safety of the world s blood supply through the research and development of methods to inactivate non-enveloped viruses and prions in human blood. Other appropriate activities may include detection methodologies for non-enveloped viruses or prions and validation assessment of inactivation processes. It is expected that some proposals may only address the extent of retained functionality of treated plasma in experiments designed to inactivate or remove pathogens, but may be performed in the absence of viral load. All other guidelines apply equally to both fund categories. These funds cover all areas of science and make up four-fifths of available funding.
Awards are limited to graduate and undergraduate students in degree programs.
Unless indicated to the contrary, the Committee will assume that failure to provide support for one applicant does not affect the viability of other applications. Stipends for applicants or assistants. Manuscript preparation and publication costs. Purchase of standard equipment and supplies that should normally be available in an institutional research laboratory. Travel to scientific meetings or symposia.